| The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions H Bolouri, JE Farrar, T Triche Jr, RE Ries, EL Lim, TA Alonzo, Y Ma, ... Nature medicine 24 (1), 103-112, 2018 | 656 | 2018 |
| Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study BV Balgobind, SC Raimondi, J Harbott, M Zimmermann, TA Alonzo, ... Blood, The Journal of the American Society of Hematology 114 (12), 2489-2496, 2009 | 501 | 2009 |
| Clinical implications of FLT3 mutations in pediatric AML S Meshinchi, TA Alonzo, DL Stirewalt, M Zwaan, M Zimmerman, ... Blood 108 (12), 3654-3661, 2006 | 467 | 2006 |
| Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase … AS Gamis, TA Alonzo, S Meshinchi, L Sung, RB Gerbing, SC Raimondi, ... Journal of Clinical Oncology 32 (27), 3021, 2014 | 448 | 2014 |
| Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group BJ Lange, FO Smith, J Feusner, DR Barnard, P Dinndorf, S Feig, ... Blood, The Journal of the American Society of Hematology 111 (3), 1044-1053, 2008 | 332 | 2008 |
| Mortality in overweight and underweight children with acute myeloid leukemia BJ Lange, RB Gerbing, J Feusner, J Skolnik, N Sacks, FO Smith, ... Jama 293 (2), 203-211, 2005 | 313 | 2005 |
| Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group MR Loken, TA Alonzo, L Pardo, RB Gerbing, SC Raimondi, BA Hirsch, ... Blood, The Journal of the American Society of Hematology 120 (8), 1581-1588, 2012 | 309 | 2012 |
| Using a combination of reference tests to assess the accuracy of a new diagnostic test TA Alonzo, MS Pepe Statistics in medicine 18 (22), 2987-3003, 1999 | 309 | 1999 |
| The genomic landscape of juvenile myelomonocytic leukemia E Stieglitz, AN Taylor-Weiner, TY Chang, LC Gelston, YD Wang, T Mazor, ... Nature genetics 47 (11), 1326-1333, 2015 | 274 | 2015 |
| Distribution‐free ROC analysis using binary regression techniques TA Alonzo, MS Pepe Biostatistics 3 (3), 421-432, 2002 | 266 | 2002 |
| Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia EL Sievers, BJ Lange, TA Alonzo, RB Gerbing, ID Bernstein, FO Smith, ... Blood, The Journal of the American Society of Hematology 101 (9), 3398-3406, 2003 | 244 | 2003 |
| Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971 AS Gamis, TA Alonzo, RB Gerbing, JM Hilden, AD Sorrell, M Sharma, ... Blood, The Journal of the American Society of Hematology 118 (26), 6752-6759, 2011 | 243 | 2011 |
| The incidence and clinical significance of nucleophosmin mutations in childhood AML P Brown, E McIntyre, R Rau, S Meshinchi, N Lacayo, G Dahl, TA Alonzo, ... Blood, The Journal of the American Society of Hematology 110 (3), 979-985, 2007 | 243 | 2007 |
| Stat3 signaling in acute myeloid leukemia: ligand-dependent and-independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor MS Redell, MJ Ruiz, TA Alonzo, RB Gerbing, DJ Tweardy Blood, The Journal of the American Society of Hematology 117 (21), 5701-5709, 2011 | 242 | 2011 |
| Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia L Sung, BJ Lange, RB Gerbing, TA Alonzo, J Feusner Blood, The Journal of the American Society of Hematology 110 (10), 3532-3539, 2007 | 242 | 2007 |
| DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update PP Anglim, TA Alonzo, IA Laird-Offringa Molecular cancer 7, 1-13, 2008 | 227 | 2008 |
| AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children … TM Cooper, J Franklin, RB Gerbing, TA Alonzo, C Hurwitz, SC Raimondi, ... Cancer 118 (3), 761-769, 2012 | 215 | 2012 |
| Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo … JA Pollard, TA Alonzo, RB Gerbing, PA Ho, R Zeng, Y Ravindranath, ... Blood, The Journal of the American Society of Hematology 115 (12), 2372-2379, 2010 | 208 | 2010 |
| Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group KE Dusenbery, WB Howells, DC Arthur, T Alonzo, JW Lee, N Kobrinsky, ... Journal of pediatric hematology/oncology 25 (10), 760-768, 2003 | 206 | 2003 |
| Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group PA Ho, TA Alonzo, RB Gerbing, J Pollard, DL Stirewalt, C Hurwitz, ... Blood, The Journal of the American Society of Hematology 113 (26), 6558-6566, 2009 | 194 | 2009 |
